INXB insider transaction filings
Inhibrx Biosciences, Inc. — 7 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-05-30. Screen INXB transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for INXB between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Inhibrx Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-30 | 4 | Deck Kelly — Chief Financial Officer | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Eckelman Brendan P. — Chief Scientific Officer | Grant/award (A): 433,888 · Grant/award (A): 40,000 · Grant/award (A): 40,000 · Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Vuori Kristiina MD — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Lappe Mark — Chief Executive Officer, Director | Grant/award (A): 621,548 · Grant/award (A): 125,000 · Grant/award (A): 14,865 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Kayyem Jon Faiz — Director | Grant/award (A): 806,075 · Grant/award (A): 6,250 · Grant/award (A): 6,250 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | FORSYTH DOUGLAS — Director | Grant/award (A): 149,564 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | MANHARD KIMBERLY — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Inhibrx Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INXB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →